Wednesday February 6, 4:15 pm ET
Live Webcast Scheduled February 13th at 2:45 p.m. EST
SAN FRANCISCO--(BUSINESS WIRE)--Osteologix Inc. (OTC BB: OLGX.OB) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview on Wednesday, February 13th, at 2:45 p.m. EST during the BIO CEO and Investor Conference at the Waldorf Astoria hotel in New York City. A live audio webcast and slide presentation will be available via the internet by visiting www.osteologix.com and clicking the link provided under ?Latest News?. An archived presentation will be available for 90 days.
About Osteologix
Osteologix is a specialty pharmaceutical company committed to developing innovative therapies for the treatment and prevention of musculoskeletal diseases. The Company?s vision is to improve the health of those afflicted with musculoskeletal diseases such as osteoporosis. Its lead product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.
For Further Information, Contact:
RedChip Companies, Inc.
500 Winderley Place, Suite 100, Orlando, FL 32751,
(800) 733-2447,Fax: (407) 644-0758,
info@redchip.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment